Despite Dem opposition, House committee advances pandemic preparedness bill sans drug shortage provisions
The House Energy & Commerce Committee advanced its pandemic preparedness reauthorization legislation Wednesday, despite firm opposition from the panel’s Democrats who also reintroduced their own “alternative” bill to reauthorize the program and help FDA combat drug shortages.
The Pandemic and All-Hazards Preparedness Act (PAHPA) is considered a must-pass piece of legislation intended to bolster the country’s ability to respond to emerging threats, and it will expire on Sept. 30 if not reauthorized. This is the first time the program is up for reauthorization since the Covid-19 pandemic emerged, and the reauthorization will extend through 2028.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.